These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35139037)

  • 1. Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.
    Mitsi E; Reiné J; Urban BC; Solórzano C; Nikolaou E; Hyder-Wright AD; Pojar S; Howard A; Hitchins L; Glynn S; Farrar MC; Liatsikos K; Collins AM; Walker NF; Hill HC; German EL; Cheliotis KS; Byrne RL; Williams CT; Cubas-Atienzar AI; Fletcher TE; Adams ER; Draper SJ; Pulido D; Beavon R; Theilacker C; Begier E; Jodar L; Gessner BD; Ferreira DM
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35139037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults.
    Parker AM; Jackson N; Awasthi S; Kim H; Alwan T; Wyllie AL; Baldwin AB; Brennick NB; Moehle EA; Giannikopoulos P; Kogut K; Holland N; Mora-Wyrobek A; Eskenazi B; Riley LW; Lewnard JA
    Clin Infect Dis; 2023 Apr; 76(7):1209-1217. PubMed ID: 36401872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children.
    Howard LM; Grijalva CG
    Curr Opin Infect Dis; 2024 Jun; 37(3):170-175. PubMed ID: 38437245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.
    Hoque MN; Akter S; Mishu ID; Islam MR; Rahman MS; Akhter M; Islam I; Hasan MM; Rahaman MM; Sultana M; Islam T; Hossain MA
    Microb Pathog; 2021 Jul; 156():104941. PubMed ID: 33962007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract.
    Lewnard JA; Bruxvoort KJ; Fischer H; Hong VX; Grant LR; Jódar L; Gessner BD; Tartof SY
    J Infect Dis; 2022 May; 225(10):1710-1720. PubMed ID: 33693636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination.
    Barman TK; Singh AK; Bonin JL; Nafiz TN; Salmon SL; Metzger DW
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
    Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
    mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of upper respiratory
    Parker AM; Jackson N; Awasthi S; Kim H; Alwan T; Wyllie AL; Baldwin AB; Brennick NB; Moehle EA; Giannikopoulos P; Kogut K; Holland N; Mora-Wyrobek A; Eskenazi B; Riley LW; Lewnard JA
    medRxiv; 2022 Oct; ():. PubMed ID: 36238718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.
    St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL
    mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial colonization of the upper airways of children positive and negative for SARS-CoV-2 during the COVID-19 pandemic.
    Ciptaningtyas VR; Hapsari R; Lestari ES; Farida H; de Mast Q; de Jonge MI
    BMC Infect Dis; 2022 Nov; 22(1):860. PubMed ID: 36396997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
    Jordan SC
    Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.